Sign In
Buy CUE
$26.84
-3.56 (-11.71%)
At Close: Jul 31, 2026
5 Stocks to Make the Most of New Analyst Coverage
02:16pm, Thursday, 13'th Feb 2020
Increased analyst coverage over the last few weeks might lead to solid price appreciation for these stocks.
The Daily Biotech Pulse: J&J Intensifies Efforts On COVID-19 Cure, Adamas Reports Positive, Long-Term Gocovri Data
02:18pm, Wednesday, 12'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 11) AbbVie Inc (NYSE: ABBV ) Acceleron Pharma Inc (NAS
Cue Biopharma to Present at the Biomarkers Series UK
01:00pm, Wednesday, 12'th Feb 2020
Cue Biopharma, Inc. (CUE), a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells within the body, announced t
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 10) AbbVie Inc (NYSE: ABBV ) Allergan plc (NYSE: AGN )
BTIG: New Data Could Propel These 3 Biotech Stocks Higher in 2020
08:31am, Monday, 03'rd Feb 2020
For those who like patterns, biotech names’ growth stories tend to look remarkably similar. These stocks are less reliant on earnings reports and more on a few select markers which can decide what d
Zacks.com featured highlights include: Independent Bank, HarborOne, Horizon Technology Finance and Cue Biopharma
03:00pm, Thursday, 30'th Jan 2020
Zacks.com featured highlights include: Independent Bank, HarborOne, Horizon Technology Finance and Cue Biopharma
4 Stocks in Focus as New Analysts Show Interest
01:55pm, Wednesday, 29'th Jan 2020
Increased analyst coverage over the last few weeks might lead to solid price appreciation for these stocks.
4 Stocks in Focus as New Analysts Show Interest
01:55pm, Wednesday, 29'th Jan 2020
Increased analyst coverage over the last few weeks might lead to solid price appreciation for these stocks.
BMO likes Seattle Genetics in premarket analyst action
12:15pm, Tuesday, 28'th Jan 2020
Acadia Healthcare (NASDAQ:ACHC) resumed with Equal Weight rating and $36 (11% upside) price target at Stephens.Applied Genetics Technologies (NASDAQ:AGTC) initiated with Buy rating and $25 (218% upsid
Cue Biopharma, Inc. (CUE), a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells within the body, announced t
Alnylam Provides Preliminary Q4 Sales for Onpattro & Givlaari
03:17pm, Monday, 13'th Jan 2020
Alnylam (ALNY) announces preliminary results for the fourth quarter and 2019 and provides other updates.
Active Participants and Digital Assets: The SEC Coins a New Term
01:00am, Monday, 05'th Aug 2019
Click HERE to find out ⭐ Active Participants and Digital Assets: The SEC Coins a New Term. | Crowdfund Insider: Global Fintech News, including Crowdfunding, Blockchain and more.
